ArticleLeukemia2026

Genomic fusion breakpoints for DNA-based measurable residual disease monitoring in pediatric acute lymphoblastic leukemia.

Arno H Houtman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.